KPRX - שולי רווח נקי ממכירות Kiora Pharmaceuticals Inc.

סמל ולוגו של המותג kiorapharma.com (KPRX)

Kiora Pharmaceuticals (KPRX) is scaling its clinical programs for the treatment of retinal pathologies to establish B2B partnerships. The development of unique biologics provides the company with high margins due to a lack of comparable alternatives. The net profit margin level visualizes these trends, where -1276.30 reflects the baseline level of the metric. Implementation efficiency is supported by specialized logistics chains with strict temperature control.

KPRX: שיעור רווח נקי Kiora Pharmaceuticals, Inc. 04.07.2022 - 19.11.2026

kiorapharma.com (KPRX) - פילוחי מדדים ודוחות פיננסיים

- שווי שוק ותחזית יעד של אנליסטים:
ניתוח ראשוני של החברה:Kiora Pharmaceuticals
סחורת הדגל של Kiora Pharmaceuticals

Selecting assets with a high margin of safety requires analyzing a business's ability to generate profit from every dollar of revenue. This indicator measures the share of net income in total sales, reflecting the ultimate efficiency of the operating model. For Kiora Pharmaceuticals (KPRX), this metric is critical when scaling KIO-301 research and expanding into the ophthalmology segment. The stability of this figure confirms the resilience of the strategy to capture the rare disease market. Assess the company's fundamental reliability by analyzing the net profit margin.